Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02601378 |
| Title | A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NOR | NLD | FRA | ESP | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
| Novartis Investigative Site | Westmead | New South Wales | 2145 | Australia | Details | |
| Novartis Investigative Site | Paris | 75231 | France | Details | ||
| Novartis Investigative Site | Leiden | 2300 RC | Netherlands | Details | ||
| Novartis Investigative Site | Oslo | 0379 | Norway | Details | ||
| Novartis Investigative Site | Madrid | 28050 | Spain | Details |